Skip to main content
Smart Investors Daily
AS

NASDAQ · ASTH

Astrana Health, Inc.

Healthcare · Medical - Care Facilities

$36.53

Down-$0.09 (-0.25%)

Updated Nov 2, 2026, 4:31 AM

SID Score

5.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.02B
P/E ratio
104.85
Dividend yield
0.00%
52-week range
$22.90 – $51.60
Volume
236.66K
Avg. volume
526.14K

Price performance · ASTH

ASTH price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

ASTH closed at $36.53 after 20 trading sessions, down 0.76% for the selected period.

Last close
$36.53
Period change
-0.76%
Period low
$35.87
Period high
$38.58
Daily close
View OHLC price history
ASTH OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$36.62$36.7599$35.835$36.53236.66K
Oct 29, 2026$37.05$37.50$36.435$36.62256.14K
Oct 28, 2026$36.90$37.8699$36.295$36.67253.57K
Oct 27, 2026$37.74$37.87$36.56$36.94310.96K
Oct 26, 2026$37.33$38.415$37.00$37.23250.15K
Oct 23, 2026$37.74$38.17$37.11$37.45196.68K
Oct 22, 2026$37.47$38.47$37.21$38.01213.89K
Oct 21, 2026$38.74$38.77$37.2027$37.35222.91K
Oct 20, 2026$37.12$38.75$37.12$38.58252.84K
Oct 19, 2026$36.81$37.40$36.17$36.90300.65K
Oct 16, 2026$38.03$38.17$36.5282$36.81240.01K
Oct 15, 2026$38.01$39.005$37.63$38.03260.52K
Oct 14, 2026$37.32$38.58$36.93$37.72446.09K
Oct 13, 2026$38.98$39.87$37.42$37.87268.16K
Oct 12, 2026$37.72$38.55$36.06$38.40294.55K
Oct 9, 2026$35.87$37.70$35.87$37.55317.05K
Oct 8, 2026$36.81$36.96$35.38$35.87351.05K
Oct 7, 2026$36.65$37.66$36.65$37.14664.51K
Oct 6, 2026$37.115$37.70$36.78$37.00227.13K
Oct 5, 2026$35.73$37.06$35.73$36.81389.92K

Latest ASTH news

The latest Smart Investors Daily articles mentioning ASTH.

ASTH research

Overview

Company profile and research snapshot.

Company profile

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$31.50
Implied upside
—
Analysts
—
ASTH recent ratings
DateFirmRatingTarget
Oct 1, 2026Freedom Capital MarketsBuy—
Sep 15, 2026OppenheimerOutperform—
Aug 11, 2026Truist SecuritiesBuy—
Aug 7, 2026BarclaysOverweight—
Jul 14, 2026TD CowenBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 19, 2026

How Investors May Respond To Alignment Healthcare (ALHC) New Medicare Plan

Alignment Healthcare recently announced Central Health Harmony, a culturally tailored HMO Medicare Advantage plan for Chinese, Korean and Vietnamese speaking seniors in Los Angeles and Orange counties, set to begin coverage in 2027 with a broad provider network including Astrana Health and Hoag. The health plan and California network expansions signal a push into multilingual, community-based care that could influence Alignment Healthcare’s member mix, benefit design costs and long-term...

Yahoo · Oct 19, 2026

Alignment Health Plan and Astrana Health Partner to Expand Access to Trusted Local Care for California Seniors

New collaboration expands access to multilingual, community-based care across seven Northern and Southern California countiesORANGE, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced a provider arrangement with Astrana Health, a leading value-based care organization with deep roots in California, that will expand in-network access to primary and specialty care for Medicare Advantage beneficiaries

Yahoo · Oct 12, 2026

Is Astrana Health (ASTH) Undervalued Following Its Verda Healthcare Partnership?

Astrana Health (ASTH) moved back into focus after Verda Healthcare announced a partnership with AstranaCare Partners in Texas and Arizona, targeting underserved communities and culturally responsive care for diverse local populations. Astrana Health’s latest partnership news landed as the share price climbed 4.68% in the last day and 2.01% over the past week, even though the 90 day share price return is down 23.37%, hinting at fresh momentum after a tougher spell despite a 28.07% total...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.